GENEVIEVE ROTA: Open Payments
NPI 1740980770 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 21 payments from 10 companies in 2025. Trend: 2023 $319 · 2024 $945 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Alnylam Pharmaceuticals Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Novo Nordisk Inc | 2 | $49 |
| PFIZER INC. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
Products named: REPATHA, LEQVIO, ELIQUIS, ONPATTRO, WAINUA, Wegovy, JARDIANCE, NEXLETOL.
Industry payments across PA — which companies pay providers there.
